CARDIOVASCULAR EFFECTS OF NPK-1886, A NEW DIHYDROPYRIDINE COMPOUND WITH CALCIUM ENTRY BLOCKING ACTIVITY

The cardiovascular effect of NPK-1886 (NPK), a novel photostable dihydropyridine compound, was studied by comparing it with that of nifedipine (Nif). In normal Wister rats (NWR), systolic blood pressure was only slightly depressed by NPK of Nif, while in three types of hypertensive rats (i.e., spontaneously hypertensive rats (SHR), renal hypertensive rats (RHR) and DOCA-saline-induced hypertensive rats (DOC-Na-R)), the hypotensive potency of NPK was more than or equal to that of Nif. The effectiveness of NPK on the normal and hypertensive models was in the following order; DOC-Na-R, RHR, SHR, NWR. Coronary perfusion flow in Langendorff''s heart was increased almost the same extent by NPK and Nif. On isolated rabbit aortic strips, the antagonist potencies of NPK, like those of Nif, were greater for calcium than for norepinephrine, serotonin and angiotensin II. the negative ino- and chronotropic potency of NPK in isolated guinea-pig right atria was less than that of Nif. The slow membrane action potentials of guinea-pig papillary muscle were suppressed by NPK, but less than by Nif, with manifestations of a reduction of .ovrhdot.Vmax and AP-duration. These results indicate that NPK has a potent hypotensive effect on hypertensive models and a weaker cardiac inhibition. The general toxicity of NPK was lower than that of Nif.